SA Asks: Which biotechs are most likely to be acquired near-term?
Which biotechs are most likely to be acquired near-term? We asked Seeking Alpha analysts Edmund Ingham and Terry Chrisomalis for their thoughts on the topic. Read more here.
businessdesk12h
M&A outlook and the year that was
Big-ticket initial public offerings could be on the cards for 2025 as experts pick a surge in mergers and acquisitions ...